• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进料流速、抗原浓度和抗体密度对凝血因子IX免疫亲和纯化的影响。

Effect of feed flow-rate, antigen concentration and antibody density on immunoaffinity purification of coagulation factor IX.

作者信息

Tharakan J P, Clark D B, Drohan W N

机构信息

Department of Chemical Engineering, Howard University, Washington, DC 20059.

出版信息

J Chromatogr. 1990 Nov 28;522:153-62. doi: 10.1016/0021-9673(90)85185-x.

DOI:10.1016/0021-9673(90)85185-x
PMID:2081750
Abstract

A simple physical model of immunoaffinity chromatography (IAC) demonstrates that immobilized monoclonal antibody (MAb) capacity in IAC purification will be a function of many parameters, including feed flow-rate and antigen concentration, and MAb density (mg MAb immobilized/ml resin). We studied IAC of factor IX, and examined the effect of parameter variation on MAb capacity. MAb capacity (1) was not affected by feed flow-rate or antigen concentration, and (2) decreased as MAb density increased. (1) Suggested that diffusion of factor IX into the resin bead was not limiting. Characteristic diffusion, convection and reaction times were calculated and used in dimensional analysis to compare their relative magnitudes. If MAb was assumed to be localized to the outer 10% of the bead volume, this analysis concluded that diffusion was not limiting, consistent with the suggestions of our experimental data. (2) Suggests that high MAb densities make MAb less accessible.

摘要

免疫亲和色谱法(IAC)的一个简单物理模型表明,IAC纯化中固定化单克隆抗体(MAb)的容量将是许多参数的函数,包括进料流速、抗原浓度和MAb密度(固定化MAb的毫克数/毫升树脂)。我们研究了因子IX的IAC,并考察了参数变化对MAb容量的影响。MAb容量:(1)不受进料流速或抗原浓度的影响;(2)随MAb密度增加而降低。(1)表明因子IX向树脂珠粒内的扩散不是限制因素。计算了特征扩散、对流和反应时间,并用于量纲分析以比较它们的相对大小。如果假设MAb定位于珠粒体积的外层10%,该分析得出扩散不是限制因素,这与我们实验数据的结论一致。(2)表明高MAb密度使MAb更难接近。

相似文献

1
Effect of feed flow-rate, antigen concentration and antibody density on immunoaffinity purification of coagulation factor IX.进料流速、抗原浓度和抗体密度对凝血因子IX免疫亲和纯化的影响。
J Chromatogr. 1990 Nov 28;522:153-62. doi: 10.1016/0021-9673(90)85185-x.
2
Evaluation of CNBr, FMP and hydrazide resins for immunoaffinity purification of factor IX.用于免疫亲和纯化凝血因子IX的溴化氰、FMP和酰肼树脂的评估。
Biotechniques. 1992 Mar;12(3):418-23.
3
Physical and biochemical characterization of five commercial resins for immunoaffinity purification of factor IX.用于因子IX免疫亲和纯化的五种市售树脂的物理和生化特性
J Chromatogr. 1992 Mar 20;595(1-2):103-11. doi: 10.1016/0021-9673(92)85150-r.
4
Development of an immunoaffinity process for factor IX purification.用于纯化凝血因子IX的免疫亲和方法的开发。
Vox Sang. 1990;58(1):21-9. doi: 10.1111/j.1423-0410.1990.tb02050.x.
5
Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5.凝血因子IX的不连续残基构成了结合抗凝血因子IX单克隆抗体A-5的表面。
Thromb Res. 2003;111(4-5):293-9. doi: 10.1016/j.thromres.2003.09.025.
6
Comparison of different ligand densities for the manufacture of CB Hep-1 immunosorbents.用于制造CB Hep-1免疫吸附剂的不同配体密度的比较。
J Biochem Biophys Methods. 2002 Aug-Sep;52(3):151-9. doi: 10.1016/s0165-022x(02)00013-1.
7
Preparation of factor IX deficient human plasma by immunoaffinity chromatography using a monoclonal antibody.
Blood. 1982 Mar;59(3):664-70.
8
Immunopurification of human coagulation factor IX using monoclonal antibodies.使用单克隆抗体对人凝血因子IX进行免疫纯化。
Thromb Haemost. 1986 Aug 20;56(1):86-9.
9
Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.血友病B患者输注单克隆抗体纯化的凝血因子IX浓缩物后体内凝血因子IX恢复情况的变异性。单克隆凝血因子IX浓缩物(Mononine)研究组
Thromb Haemost. 1995 May;73(5):779-84.
10
Immunoaffinity chromatography: an introduction to applications and recent developments.免疫亲和色谱法:应用及最新进展介绍
Bioanalysis. 2010 Apr;2(4):769-90. doi: 10.4155/bio.10.31.